Zhou X, Liu Z, Cheng X, Zheng Y, Zeng F, He Y
Department of Vascular and Thyroid, The Affiliated Hospital of Sichuan Medical University, Luzhou, Sichuan Province, P. R. China.
Department of Lymphoma and Myeloma, Division of Cancer Medicine, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Cell Death Dis. 2015 Dec 3;6(12):e2012. doi: 10.1038/cddis.2015.342.
Mechanisms involved in inflammatory development during acute pancreatitis (AP) are largely vague, especially in the transformation of acute edematous pancreatitis (AEP) into acute necrotizing pancreatitis (ANP). This current study aims to investigate the functions of Traf6 in different AP models in vitro and in vivo, and to identify the possible regulatory mechanism in the progression of inflammation from mild to severe. Our data revealed that the level of Traf6 expression was significantly increased in the mild AP induced by caerulein, and the upregulation of Traf6 played a protective role in acinar cells against caerulein-induced apoptosis. In contrast, only Traf6 protein but not mRNA was downregulated in the severe ANP induced by combination treatment of caerulein and LPS. Mechanistic studies showed that LPS upregulated the levels of Socs1 and Socs3 expressions in acinar cells, Socs1 and Socs3 interacted Traf6 directly and degraded Traf6 protein via polyubiquitination, thereby counteracted the protective function of Traf6. In vivo study further showed that combination treatment of caerulein and LPS failed to induce an ANP model in the TLR4 knockout mice, and the level of Traf6 expression in the pancreatic tissues remained the same as that from the acute edematous pancreatitis (AEP) mouse. Taken together, our study reveals that Traf6 functioned as a protective factor in the progression of AP, and LPS-induced Socs1 and Socs3 exacerbate mild AP to severe AP, which provides evidence for developing a new therapeutic target to combat AP.
急性胰腺炎(AP)炎症发展过程中涉及的机制在很大程度上尚不明确,尤其是在急性水肿性胰腺炎(AEP)向急性坏死性胰腺炎(ANP)转变的过程中。本研究旨在探讨Traf6在体外和体内不同AP模型中的功能,并确定炎症从轻度发展到重度过程中可能的调节机制。我们的数据显示,在雨蛙素诱导的轻度AP中,Traf6表达水平显著升高,Traf6的上调对腺泡细胞抵抗雨蛙素诱导的凋亡起到保护作用。相反,在雨蛙素和脂多糖联合处理诱导的重度ANP中,只有Traf6蛋白而非mRNA水平下调。机制研究表明,脂多糖上调腺泡细胞中Socs1和Socs3的表达水平,Socs1和Socs3直接与Traf6相互作用,并通过多聚泛素化降解Traf6蛋白,从而抵消Traf6的保护功能。体内研究进一步表明,雨蛙素和脂多糖联合处理未能在TLR4基因敲除小鼠中诱导出ANP模型,胰腺组织中Traf6的表达水平与急性水肿性胰腺炎(AEP)小鼠的相同。综上所述,我们的研究表明Traf6在AP进展过程中起到保护因子的作用,脂多糖诱导的Socs1和Socs3将轻度AP恶化为重度AP,这为开发对抗AP的新治疗靶点提供了证据。